{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:03:47Z","timestamp":1771009427507,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T00:00:00Z","timestamp":1247011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Postpolycythaemic myelofibrosis (PPMF) is a known complication of polycythaemia vera (PV) but information regarding its incidence and predisposing factors is not well defined. In 116 subjects consecutively diagnosed with PV in a single institution (median age 62\u2003years, range: 20\u201388), the probability of PPMF was analysed by the Kaplan\u2013Meier method, followed by the log\u2010rank test. With a mean follow\u2010up of 8\u2003years (95% confidence interval: 6\u00b76\u20139), 17 patients had evolved into PPMF (15%). The probability of evolution to PPMF was 16% at 10\u2003years and 34% at 15\u2003years. Age, gender, spleen size, leucocytosis, thrombocytosis or cytoreductive treatment were not associated with an increased risk of PPMF. The actuarial probability of PPMF at 15\u2003years was higher in those patients presenting at diagnosis with endogenous megakaryocytic colony formation (59% when present <jats:italic>versus<\/jats:italic> 10% when absent, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b703), an elevated serum lactate dehydrogenase (LDH) level (69% vs. 23% in patients with normal LDH, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b704), and in those who were heterozygous for the <jats:italic>JAK2<\/jats:italic> V617F mutation (55% vs. 17% in heterozygotes, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b704). In conclusion, PPMF is a frequent complication in PV patients at 15\u2003years with the risk being higher in patients with increased LDH, endogenous megakaryocytic colony formation or a high <jats:italic>JAK2<\/jats:italic> V617F allele burden.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2009.07804.x","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T22:42:12Z","timestamp":1247179332000},"page":"504-509","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients"],"prefix":"10.1111","volume":"146","author":[{"given":"Alberto","family":"Alvarez\u2010Larr\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Bellosillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"Mart\u00ednez\u2010Avil\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Saumell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Salar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Abella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Florensa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Besses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404914"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood.V57.4.781.781","article-title":"Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts","volume":"57","author":"Castro\u2010Malaspina H.","year":"1981","journal-title":"Blood"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03688.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1962.tb07186.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-064626"},{"key":"e_1_2_6_7_1","first-page":"144","article-title":"Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies","volume":"23","author":"Ellis J.T.","year":"1986","journal-title":"Seminars in Hematology"},{"key":"e_1_2_6_8_1","first-page":"271","article-title":"Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia","volume":"9","author":"Florensa L.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-9-199511010-00003"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830270409"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb07595.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb04310.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050595"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3900"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.062"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2008.05.006"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb03289.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-121434"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90136-2"},{"key":"e_1_2_6_21_1","first-page":"499","article-title":"Polycythaemia vera: clinical studies on a series of 127 patients managed without radiation therapy","volume":"33","author":"Perkins J.","year":"1964","journal-title":"The Quarterly Journal of Medicine"},{"key":"e_1_2_6_22_1","first-page":"363","article-title":"Postpolycythemia myeloid metaplasia: experience with a large cohort of patients","volume":"25","author":"Randi M.L.","year":"1994","journal-title":"Journal of Medicine"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.134.1.113"},{"key":"e_1_2_6_24_1","first-page":"79","article-title":"The evolution into and the treatment of late stage polycythemia vera","volume":"13","author":"Silverstein M.N.","year":"1976","journal-title":"Seminars in Hematology"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0349"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood.V93.1.125","article-title":"Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c\u2010mpl mutation or to an autocrine stimulation by Mpl\u2010L","volume":"93","author":"Taksin A.L.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21645"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404854"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-064287"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2485"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2009.07804.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2009.07804.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:22:40Z","timestamp":1697455360000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2009.07804.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-2141.2009.07804.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07804.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,11]]},"assertion":[{"value":"2009-08-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}